In his presentation, Dr. Cees Vermeer will explain that vitamin K insufficiency is widespread among the Western population and that increased vitamin K2 intake may improve public health and prolong life expectation. In the second part of his talk he will comment on some recent studies performed at VitaK, Maastricht University, underpinning the conclusion that MenaQ7 is the only vitamin K supplement of which health effects have been demonstrated in a 3-year clinical trial.
CEO of VitaK BV / R&D Partner with
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.